Advanced search
Publication Cover
Gut Microbes Volume 12, 2020 - Issue 1
Submit an article Journal homepage
3,323
Views
21
CrossRef citations to date
0
Altmetric
Research paper

How oral probiotics affect the severity of an experimental model of progressive multiple sclerosis? Bringing commensal bacteria into the neurodegenerative process

Leyre Mestrea Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;b Red Española de Esclerosis Múltiple (REEM)Correspondence[email protected] [email protected]
View further author information
,
Francisco J. Carrillo-Salinasa Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;c Tufts University School of Medicine, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0002-7936-5859View further author information
ORCID Icon,
Ana Feliúa Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;b Red Española de Esclerosis Múltiple (REEM)ORCID Iconhttps://orcid.org/0000-0002-1157-1525View further author information
ORCID Icon,
Miriam Mechaa Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;b Red Española de Esclerosis Múltiple (REEM)View further author information
,
Graciela Alonsoa Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;b Red Española de Esclerosis Múltiple (REEM)View further author information
,
Carmen Espejob Red Española de Esclerosis Múltiple (REEM);d Servei de Neurología-Neuroimmunología, Centre d’Esclerosi Múltiple de Catalunya, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Barcelona, Spain;e Universitat Autònoma de Barcelona, Bellaterra, SpainView further author information
,
Laura Calvo-Barreirod Servei de Neurología-Neuroimmunología, Centre d’Esclerosi Múltiple de Catalunya, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Barcelona, Spain;e Universitat Autònoma de Barcelona, Bellaterra, SpainView further author information
,
José L. Luque-Garcíaf Analytical Chemistry Department, Complutense University of Madrid, Madrid, SpainView further author information
,
Héctor Estevezf Analytical Chemistry Department, Complutense University of Madrid, Madrid, SpainView further author information
,
Luisa María Villarb Red Española de Esclerosis Múltiple (REEM);g Immunology Department, Hospital Universitario Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, SpainORCID Iconhttps://orcid.org/0000-0002-9067-3668View further author information
ORCID Icon &
Carmen Guazaa Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain;b Red Española de Esclerosis Múltiple (REEM)View further author information
 show all
Article: 1813532 | Received 24 Feb 2020, Accepted 12 Aug 2020, Published online: 08 Sep 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Dorota Kujawa, Lukasz Laczmanski, Slawomir Budrewicz, Anna Pokryszko-Dragan & Maria Podbielska. (2023) Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. Gut Microbes 15:2.
Read now
Chen Wang, Junying Bai, Xiaoyong Chen, Jiajia Song, Yu Zhang, Hongwei Wang & Huayi Suo. (2023) Gut microbiome-based strategies for host health and disease. Critical Reviews in Food Science and Nutrition 0:0, pages 1-16.
Read now
Jie Cai, Zhongxu Chen, Wei Wu, Qinlu Lin & Ying Liang. (2022) High animal protein diet and gut microbiota in human health. Critical Reviews in Food Science and Nutrition 62:22, pages 6225-6237.
Read now
Lorrie L. Blais, Theresa L. Montgomery, Eyal Amiel, Paula B. Deming & Dimitry N. Krementsov. (2021) Probiotic and commensal gut microbial therapies in multiple sclerosis and its animal models: a comprehensive review. Gut Microbes 13:1.
Read now

Articles from other publishers (17)

Robert Lalonde & Catherine Strazielle. (2023) Probiotic Influences on Motor Skills: A Review. Current Neuropharmacology 21:12, pages 2481-2486.
Crossref
Nishant Gupta, Ashok Kumar Agarwal, M. Al-Dossari & N.S. Abd EL-Gawaad. (2023) Psychobiotic potential of Lactiplantibacillus plantarum: Current perspective in neurodegeneration and geriatric therapies. Brain Behavior and Immunity Integrative, pages 100038.
Crossref
Faezeh Golpour, Mehrsa Abbasi-Alaei, Fatemeh Babaei, Mohammadreza Mirzababaei, Siavash Parvardeh, Ghazaleh Mohammadi & Marjan Nassiri-Asl. (2023) Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomedicine & Pharmacotherapy 163, pages 114763.
Crossref
Matteo Bronzini, Alessandro Maglione, Rachele Rosso, Manuela Matta, Federica Masuzzo, Simona Rolla & Marinella Clerico. (2023) Feeding the gut microbiome: impact on multiple sclerosis. Frontiers in Immunology 14.
Crossref
Diana Boraschi, Paola Italiani, Paola Migliorini & Paola Bossù. (2023) Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases. Frontiers in Immunology 14.
Crossref
Behnam Hashemi, Maryam Abdollahi, Sanaz Abbaspour-Aghdam, Ali Hazrati, Kosar Malekpour, Shahla meshgi, Hossein Samadi Kafil, Farhood ghazi, Mehdi Yousefi, Leila Roshangar & Majid Ahmadi. (2023) The effect of probiotics on immune responses and their therapeutic application: A new treatment option for multiple sclerosis. Biomedicine & Pharmacotherapy 159, pages 114195.
Crossref
Angela Dziedzic & Joanna Saluk. (2022) Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment. International Journal of Molecular Sciences 23:22, pages 14478.
Crossref
Esther Melamed, Jamie L. Palmer & Cara Fonken. (2022) Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis. Frontiers in Molecular Neuroscience 15.
Crossref
Wenbin Liu, Meiyang Fan, Wen Lu, Wenhua Zhu, Liesu Meng & Shemin Lu. (2022) Emerging Roles of T Helper Cells in Non-Infectious Neuroinflammation: Savior or Sinner. Frontiers in Immunology 13.
Crossref
Shailesh K. Shahi, Meeta Yadav, Sudeep Ghimire & Ashutosh K. Mangalam. 2022. Microbiome in Neurological Disease. Microbiome in Neurological Disease 185 215 .
Zahra Zangeneh, Ahya Abdi-Ali, Kianoosh Khamooshian, Amirhoushang Alvandi & Ramin Abiri. (2021) Bacterial variation in the oral microbiota in multiple sclerosis patients. PLOS ONE 16:11, pages e0260384.
Crossref
Shahrzad Mirashrafi, Seyedeh Zahra Hejazi Taghanaki, Faezeh Sarlak, Amir Reza Moravejolahkami, Mohammad Ali Hojjati Kermani & Mohsen Haratian. (2021) Effect of probiotics supplementation on disease progression, depression, general health, and anthropometric measurements in relapsing‐remitting multiple sclerosis patients: A systematic review and meta‐analysis of clinical trials. International Journal of Clinical Practice 75:11.
Crossref
Laura Ghezzi, Claudia Cantoni, Gabriela V. Pinget, Yanjiao Zhou & Laura Piccio. (2021) Targeting the gut to treat multiple sclerosis. Journal of Clinical Investigation 131:13.
Crossref
Giuseppe Murdaca, Monica Greco, Matteo Borro & Sebastiano Gangemi. (2021) Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmunity Reviews 20:7, pages 102845.
Crossref
Deniz Erturk-Hasdemir, Javier Ochoa-Repáraz, Dennis L. Kasper & Lloyd H. Kasper. (2021) Exploring the Gut-Brain Axis for the Control of CNS Inflammatory Demyelination: Immunomodulation by Bacteroides fragilis’ Polysaccharide A. Frontiers in Immunology 12.
Crossref
Jinchi Jiang, Chuanqi Chu, Caie Wu, Chen Wang, Chengcheng Zhang, Tiantian Li, Qixiao Zhai, Leilei Yu, Fengwei Tian & Wei Chen. (2021) Efficacy of probiotics in multiple sclerosis: a systematic review of preclinical trials and meta-analysis of randomized controlled trials. Food & Function 12:6, pages 2354-2377.
Crossref
Stephanie Trend, Jonatan Leffler, Anderson P. Jones, Lilian Cha, Shelley Gorman, David A. Brown, Samuel N. Breit, Allan G. Kermode, Martyn A. French, Natalie C. Ward & Prue H. Hart. (2021) Associations of serum short-chain fatty acids with circulating immune cells and serum biomarkers in patients with multiple sclerosis. Scientific Reports 11:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.